DR2X-Dy special research factor, care for women's health
In the field of women's health, DR.ONE has always been committed to providing high-quality nutritional supplements based on its innovation and science. Recently, it announced the launch of a new women's health product - Yueyuehong. With its unique formula, this product is designed to fully support the physical health of women during menstruation and menopause.
The core ingredients of this product include soy isoflavones and DR2X-Dy specially developed factors. Soy isoflavones and DR2X-Dy specially developed factors lead the way, and multiple ingredients work synergistically to protect women's health. Soy isoflavones, a type of phytoestrogen, have been extensively studied for their potential benefits in regulating female hormone levels and relieving menstrual discomfort and menopausal symptoms. It can help balance hormone fluctuations and reduce symptoms like hot flashes, night sweats, and mood swings.
Soy isoflavones are a class of flavonoid compounds, which are secondary metabolites formed during the growth process of soybeans and have biological activity. They have a similar structure to the estrogen secreted by the human body, so they are called phytoestrogens. Soy isoflavones are similar in structure to natural estrogen secreted by the human body and can bind to estrogen receptors in the body, but isoflavones only have weak estrogen effects. When there is a lack of estrogen in the human body, its binding can supplement estrogen; when the estrogen level in the body is too high, it will competitively bind to the estrogen receptor and inhibit estrogen, which is equivalent to lowering the level of estrogen. Therefore, isoflavones have a bidirectional regulatory effect and are known as regulators of female estrogen levels.
A large number of clinical trials have confirmed that soy isoflavones can effectively prevent or alleviate symptoms caused by the decrease of estrogen in menopausal women, such as irritability, osteoporosis, memory loss, menopausal hot flashes, sweating, insomnia, etc. Therefore, appropriate supplementation of soy isoflavones by women entering menopause can help them to smoothly go through menopause and improve their quality of life during this special period.
DR2X-Dy, a carefully developed and unique scientifically formulated ingredient, is the core highlight of DR.ONE's monthly red product. This unique factor is a delicate combination of two key ingredients: chiro-inositol (also known as D-inositol) and myo-inositol (or myo-inositol), which play vital roles in the body's cellular metabolism and energy production.
DR2X-Dy has also been found to have a positive effect on alleviating a range of symptoms related to endocrine changes, especially premenstrual syndrome (PMS) and menopausal symptoms in women. By regulating hormone levels in the body, especially pathways related to estrogen metabolism, this factor can help alleviate mood swings, breast tenderness, bloating and other discomforts during PMS. It can also help alleviate hot flashes, mood swings, sleep disorders and other problems that menopausal women may encounter, thereby improving their quality of life.
In addition, for patients with polycystic ovary syndrome, DR2X-Dy plays a key role in regulating hormone levels. Patients with polycystic ovary syndrome often have excessively high levels of androgen. Chiro-inositol and myo-inositol can participate in regulating the endocrine system, help balance the secretion of androgens, and reduce a series of adverse effects caused by high androgen levels, such as hirsutism and acne. They can work synergistically to affect the function of the hypothalamus-pituitary-ovarian axis, normalize hormone secretion, and thereby improve the ovulation function of polycystic patients and increase the chance of conception. Polycystic patients often have multiple small follicles in their ovaries, but these follicles have difficulty maturing and ovulating. Chiro-inositol and myo-inositol can provide a favorable microenvironment for the growth of follicles, promote the maturation of follicles and the normalization of ovulation process, help the ovaries restore normal physiological functions, and reduce the damage of polycystic ovary syndrome to the reproductive system. At the same time, this positive impact on ovarian function also helps maintain women's normal menstrual cycle and reduce the occurrence of menstrual disorders, amenorrhea and other problems.
In summary, DR2X-Dy specialized factor, with its unique combination of chiro-inositol and myo-inositol, not only plays an important role in promoting cell health and energy metabolism, but also shows significant advantages in regulating blood sugar, improving polycystic ovary syndrome, and alleviating specific women's health problems, becoming a shining pearl in the DR.ONE brand.
In addition to the core ingredients, the product also contains auxiliary ingredients such as chaste berry powder, L-theanine, 5-HTP and folic acid. Chasteberry powder is a traditional herbal remedy believed to regulate the menstrual cycle and relieve period pain. L-theanine is an amino acid that can promote relaxation, reduce anxiety and stress, and is beneficial for improving menopausal sleep disorders. 5-HTP is a precursor to serotonin and helps improve mood and sleep. Folic acid is particularly important for women's health, especially during pregnancy, to help prevent neural tube defects.
This new product from DR.ONE is a perfect example of the perfect combination of science and nature. DR.ONE understands the challenges women face during menstruation and menopause, so these ingredients were carefully selected to ensure comprehensive health support. This scientifically proven formula is designed to help women better manage their health conditions and improve quality of life.
With the launch of this new product, DR.ONE once again demonstrates its leadership in women's health. We look forward to DR.ONE helping more women achieve better health and well-being.
Since 2008, the DR.ONE brand has been conceiving of the idea of integrating Chinese and Western health solutions and envisioning the establishment of the Hong Kong Chinese Medicine Research Institute. In 2011, we clarified our market positioning and focused on health solutions for Asians. In 2018, we increased brand awareness through expert exchanges. In 2020, we will deepen the integration of Chinese medicine and modern medicine, strengthen international cooperation and promote innovation. By 2024, the Hong Kong Chinese Medicine Research Institute will combine traditional Chinese medicine theory with modern technology, and DR.ONE will be officially established in Hong Kong to realize a health solution that integrates Chinese and Western medicine.
DR.ONE is not only committed to product research and development and innovation, but also pursues excellence in quality control. The brand is equipped with advanced production equipment and a strict quality management system to ensure that products are strictly controlled from raw material procurement to production and processing and finished product inspection. We use high-quality raw materials, scientific proportions and modern technology to ensure that the products are safe, efficient and have no side effects. DR.ONE has been awarded international authoritative certifications such as FDA, GMP, HACCP, ISO, and has efficacy testing certification from a third-party authoritative organization, which fully guarantees the product's excellent quality and reliable effects, winning the trust of consumers.